Broadcom vs. Intel: Which Chip Stock Is a Better Buy in 2026?

Broadcom reported FY2025 revenue of nearly $64B, up about 24%, and net income of roughly $23B; analysts see revenue rising 66% to $106B and profit nearly doubling to more than $44B this year. Intel’s FY2025 revenue fell about 0.5% to nearly $53B, with a $267M net loss and negative $4.9B free cash flow, while its foundry expansion carries significant execution costs. The article favors Broadcom for 2026, citing stronger near-term AI-driven growth and a more reasonable forward P/E; Intel’s projected FY2026 sales growth of 19% to $62.3B comes alongside a projected $11B net loss.

Analysis

The key distinction is cash-flow proof versus execution optionality. Broadcom’s custom accelerators and networking can benefit even as hyperscalers diversify away from off-the-shelf GPUs; that is not automatically bearish for NVIDIA, since total AI infrastructure spend may grow, but it raises substitution risk if custom silicon takes a larger share of inference workloads. The counter-risk is correlated customer budgets: a pause by a few hyperscalers could hit Broadcom’s growth narrative disproportionately. Verify announced customer programs translate into recognized revenue and durable orders, rather than treating partnership breadth as independent demand.

Intel’s foundry upside is an option, not yet evidence of a competitive manufacturing business. Announced collaborations and public-sector capital can reduce funding risk, but do not establish external-customer wafer volume, yields, or acceptable returns on the buildout. Those milestones matter more than headline deal count; failure would leave investors bearing capex and legacy-product share pressure. AMD and NVIDIA remain potential share beneficiaries if Intel’s product or process execution slips.

Near term, sentiment and AI estimates may already embed substantial Broadcom execution, so a miss in accelerator growth, VMware retention, or cash conversion could compress the multiple. Over 1–3 months, focus on guidance, customer concentration and capex conversion; over 6–18 months, Intel’s decisive tests are process milestones, foundry customer qualification and capital intensity. Treat the article’s estimates and partnership claims as items to verify against filings and earnings disclosures, not as realized economics. The contrarian risk is that Intel’s low apparent sales multiple is not cheap if losses and cash burn persist; conversely, Broadcom’s premium could be underpricing the value of a diversified infrastructure-software cash-flow base, but SBC-adjusted cash generation needs scrutiny.

Key Decisions for Investors

• Prefer AVGO over INTC for a growth allocation, but scale in around earnings rather than chase estimate-driven momentum. Track accelerator revenue/order conversion, VMware bookings or retention, and free cash flow after accounting for SBC; a material guidance reset or weakening cash conversion falsifies the near-term thesis.
• For a relative-value expression, consider a modest, beta-aware long AVGO / short INTC pair rather than an outright Intel short. Keep the short leg small or defined-risk: foundry/customer announcements or public funding headlines can trigger sharp squeezes without proving attractive foundry economics.
• Use Intel foundry milestones as an alert, not a buy signal: seek independently verifiable external wafer commitments, yield/process progress, and capex/FCF trajectory. Reassess if customer qualification and process execution improve while cash burn stabilizes; deteriorating milestones strengthen the underperformance thesis.
• Monitor hyperscaler capex and Broadcom customer concentration over the next 1–3 months. Broad-based capex cuts, delayed custom-chip deployments, or evidence of customer insourcing would challenge AVGO; continued deployment with resilient networking demand would support holding the relative preference.